Antiplatelet agents for preventing pre-eclampsia and its complications
Field | Value | Language |
dc.contributor.author | Duley, L | |
dc.contributor.author | Meher, S | |
dc.contributor.author | Hunter, KE | |
dc.contributor.author | Seidler, AL | |
dc.contributor.author | Askie, LM | |
dc.date.accessioned | 2021-03-23T05:43:47Z | |
dc.date.available | 2021-03-23T05:43:47Z | |
dc.date.issued | 2019 | en_AU |
dc.identifier.uri | https://hdl.handle.net/2123/24716 | |
dc.description.abstract | We set out to assess the ability of antiplatelet agents, such as aspirin and dipyridamole, to prevent women from developing pre-eclampsia during pregnancy and to improve health outcomes for them and their babies. We also wanted to find out whether these medicines had any undesirable effects for the mother or baby. | en_AU |
dc.publisher | Cochrane Database of Systematic Reviews | en_AU |
dc.rights | Copyright All Rights Reserved | en_AU |
dc.title | Antiplatelet agents for preventing pre-eclampsia and its complications | en_AU |
dc.type | Article | en_AU |
dc.identifier.doi | 10.1002/14651858.CD004659.pub3 | |
usyd.faculty | SeS faculties schools::Faculty of Medicine and Health::NHMRC Clinical Trials Centre | en_AU |
workflow.metadata.only | No | en_AU |
Associated file/s
Associated collections